US Map / Wisconsin
State WI

Clinical Trials in Wisconsin

Wisconsin is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Wisconsin and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 192 actively recruiting studies with Wisconsin sites out of 192 registered in total. The busiest research areas in Wisconsin are Acute Myeloid Leukemia, Breast Cancer, Heart Failure. Leading sponsors running trials in the state include University of Wisconsin, Madison, National Cancer Institute (NCI), Medical College of Wisconsin. By stage, Wisconsin trials break down as Phase 1 (26), Phase 2 (44), Phase 3 (59), Phase 4 (2).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
192
Recruiting Now
192
← Back to US Map
Top Conditions in Wisconsin
Acute Myeloid Leukemia (4)Breast Cancer (4)Heart Failure (4)Multiple Myeloma (3)Chronic Lymphocytic Leukemia (3)Ovarian Cancer (3)Pancreatic Adenocarcinoma (3)Stage III Pancreatic Cancer AJCC v8 (3)Advanced Solid Tumors (2)Advanced Solid Tumor (2)Non-Small Cell Lung Cancer (NSCLC) (2)Endometrial Cancer (2)

Frequently Asked Questions — Clinical Trials in Wisconsin

How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 192 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 192. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Acute Myeloid Leukemia, Breast Cancer, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Wisconsin

NCT07218926 Phase 3
Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastr...
Condition
Gastrointestinal Neoplasms
Enrollment
450 pts
Location
United States, Australia, Belgium
Sponsor
GlaxoSmithKline
View Trial →
NCT07507643 Phase 3
Recruiting
A Study of Methylprednisolone in People Having Liver Surgery
Condition
Hepatectomy
Enrollment
750 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
View Trial →
NCT05920356 Phase 3
Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab P...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT07278466 N/A
Recruiting
The COMParing App Support Strategies Study
Condition
Depression, Anxiety
Enrollment
688 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06152575 Phase 3
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in P...
Condition
Multiple Myeloma
Enrollment
492 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
View Trial →
NCT03802695 Phase 1
Recruiting
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation fo...
Condition
Acute Myeloid Leukemia
Enrollment
300 pts
Location
United States
Sponsor
Orca Biosystems, Inc.
View Trial →
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Mod...
Condition
Colitis, Ulcerative
Enrollment
120 pts
Location
United States, Australia, Belgium
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06269081 N/A
Recruiting
Testing Two Interventions to Improve Health Outcomes and Quality of Life Among R...
Condition
HIV
Enrollment
352 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT05313165 N/A
Recruiting
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-St...
Condition
Critical Limb Ischemia
Enrollment
100 pts
Location
United States
Sponsor
LimFlow, Inc.
View Trial →
NCT06106477 N/A
Recruiting
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related ...
Condition
Breast Cancer
Enrollment
20 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT06218875 N/A
Recruiting
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endopros...
Condition
AAA - Abdominal Aortic Aneurysm
Enrollment
2,000 pts
Location
United States, Australia, Austria
Sponsor
W.L.Gore & Associates
View Trial →
NCT07226167 N/A
Recruiting
Hearing Aid Benefit in Real-World Noisy Environments
Condition
Hearing Aid
Enrollment
45 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT05125302 Phase 3
Recruiting
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets f...
Condition
Migraine
Enrollment
1,059 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
View Trial →
NCT07684235 Phase 3
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of ...
Condition
Obesity
Enrollment
3,200 pts
Location
United States, Australia, Japan
Sponsor
Amgen
View Trial →
NCT05624996 Phase 3
Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for...
Condition
Locally Advanced Lung Non-Small Cell Carcinoma
Enrollment
474 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT07304440 Phase 1, Phase 2
Recruiting
Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study
Condition
Autism Spectrum Disorder
Enrollment
100 pts
Location
United States
Sponsor
Adia Med of Winter Park LLC
View Trial →
NCT05334004 Phase 1
Recruiting
Lopinavir/Ritonavir in PLWH With High-Grade AIN
Condition
High-Grade Anal Intraepithelial Neoplasia
Enrollment
21 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06256458 N/A
Recruiting
Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Traum...
Condition
Fractures, Bone
Enrollment
200 pts
Location
United States
Sponsor
Artoss Inc.
View Trial →
NCT06617949 EARLY_Phase 1
Recruiting
Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder...
Condition
Substance Use Disorder (SUD)
Enrollment
20 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT07176208 Phase 1
Recruiting
Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-...
Condition
Cannabis, Drug Effects
Enrollment
48 pts
Location
United States
Sponsor
Food and Drug Administration (
View Trial →
NCT05899608 Phase 3
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patie...
Condition
Non-Small Cell Lung Cancer
Enrollment
1,600 pts
Location
United States, Belgium, Canada
Sponsor
Summit Therapeutics
View Trial →
NCT05659381 Phase 3
Recruiting
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary P...
Condition
Stage III Ovarian Cancer
Enrollment
220 pts
Location
United States
Sponsor
GOG Foundation
View Trial →
NCT06388967 N/A
Recruiting
Pancreatic Cancer Detection Consortium
Condition
Pancreatic Cancer
Enrollment
2,000 pts
Location
United States, Japan, South Korea
Sponsor
City of Hope Medical Center
View Trial →
NCT06407232 Phase 3
Recruiting
Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
Condition
Cytomegalovirus Infections
Enrollment
90 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
Page 2 of 8 — 192 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology